Brugières, Laurence
Institut Gustave Roussy · Fondation Gustave Roussy
6 papers on CoChatORCID 0000-0002-7798-6651
Most cited papers
- Verified
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology
Cancer-related Molecular PathwaysMultiple and Secondary Primary Cancers
Cited by 760
- Verified
Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 617
- Verified
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research
Cancer-related Molecular PathwaysMultiple and Secondary Primary Cancers
Cited by 534
- Verified
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
Bougeard, G., Sesboüé, R., Baert-Desurmont, S., Vasseur, S., Martin, C., Tinat, J., Brugières, L., Chompret, A., Paillerets, B. B.-D., Stoppa-Lyonnet, D., et al. (2008) · Journal of Medical Genetics
Cancer-related Molecular PathwaysGenetic factors in colorectal cancer
Cited by 230
- Verified
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial
Audinot, B., Drubay, D., Gaspar, N., Mohr, A., Cordero, C., Marec-Bérard, P., Lervat, C., Piperno-Neumann, S., Jimenez, M., Mansuy, L., et al. (2024) · Annals of Oncology
Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 38
- Verified
Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
Chappuy, H., Bouazza, N., Minard-Colin, V., Patte, C., Brugières, L., Landman-Parker, J., Auvrignon, A., Davous, D., Pacquement, H., Orbach, D., et al. (2013) · BMJ Open
Ethics in Clinical ResearchEthics and Legal Issues in Pediatric Healthcare
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free